Aurilion was founded by someone who experienced the problem firsthand — and had the technical foundation to build a real solution.
Claire's path to Aurilion started with a firsthand encounter with a problem that most people in the industry accept as the cost of doing business. While working within formulation-adjacent roles and exploring a product launch of her own, she saw how fragmented, reactive, and resource-intensive formulation R&D still is — even in well-resourced teams.
With a background in health science, chemical formulation, and software development, Claire was positioned to understand both the scientific complexity and the infrastructure gap. She founded Aurilion to bring AI-powered intelligence upstream — helping formulation teams develop, validate, and manage formulations before costly laboratory resources are committed.
Aurilion's proprietary PLRS (Pre-Lab Readiness Score), backed by a filed provisional patent, is a direct result of that vision — a systematic way to evaluate formulation readiness before laboratory resources are committed. Aurilion is starting with Beauty & Personal Care, with a platform architecture designed to expand across formulation-intensive industries.
Connect on LinkedIn"To bring AI-powered formulation intelligence upstream — so that R&D teams can develop, validate, and manage formulations with greater confidence before costly laboratory resources are committed."
The global Beauty & Personal Care market is a $500B+ industry — and it represents just the beachhead. Formulation-intensive R&D workflows remain largely manual and fragmented across the entire category. Aurilion is building the AI-native infrastructure layer for formulation R&D, starting with Beauty & Personal Care and designed to expand from there.
Global cosmetics and skincare market — largely underserved by modern R&D software infrastructure
Aurilion compresses the formulation intake and validation process from days to minutes
Provisional patent filed on the PLRS scoring methodology — proprietary, defensible IP
Currently raising our first institutional round. Reach out for data room access.
Enterprise SaaS targeting medium-to-large cosmetic laboratories with recurring revenue
Platform live and operational. First laboratory users onboarded. Real formulations being processed today.
Reach out directly and we'll share our deck and data room.